Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Rochester, New York 14609


The objective of this study is to evaluate the safety of Besivance (besifloxacin ophthalmic suspension, 0.6%) compared to vehicle.


Inclusion Criteria: - Subjects must have a clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge (crusty or sticky eyelids) and redness in at least one eye. - Subjects who are willing to discontinue contact lens wear for the duration of the study. - Subjects who are able and willing to comply with all treatment and follow- up/study procedures. Exclusion Criteria: - Subjects who have any uncontrolled systemic disease or debilitating disease. - Subjects with a known hypersensitivity or contraindications to Besivance, fluoroquinolones, or any of the ingredients in the study drugs. - Subjects who are expected to require disallowed concurrent systemic or ocular therapy(either eye)during or prior to study start. (ie, NSAIDs, corticosteroids, mast cell stabilizers, antihistamines, decongestants or antimicrobial therapy) - Subjects having ocular surgery (including laser surgery) in either eye within six weeks prior to entry into this study. - Subjects with suspected viral or allergic conjunctivitis or any other disease conditions that could interfere with the efficacy and safety evaluations of the study medication. - Subjects with suspected iritis. - Subjects with a history of recurrent corneal erosion syndrome, either idiopathic or secondary to previous corneal trauma or dry eye syndrome. - Subjects with any active ulcerative keratitis, specifically any epithelial loss greater than punctate keratitis. - Subjects who are immune compromised.



Primary Contact:

Study Director
Laura Trusso, MS
Bausch & Lomb, Inc.

Backup Contact:


Location Contact:

Rochester, New York 14609
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.